Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation
- 31 January 2009
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 215 (1), 5-19
- https://doi.org/10.1016/j.expneurol.2008.09.003
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Identification, classification, and expression ofRAGEgene splice variantsThe FASEB Journal, 2007
- Constitutively active STAT6 predisposes toward a lymphoproliferative disorderBlood, 2007
- CD200 is induced by ERK and is a potential therapeutic target in melanomaJCI Insight, 2007
- Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune UveoretinitisThe American Journal of Pathology, 2007
- CD200 Ligand–Receptor Interaction Modulates Microglial ActivationIn VivoandIn Vitro: A Role for IL-4Journal of Neuroscience, 2007
- Elevated Neuronal Expression of CD200 Protects Wlds Mice from Inflammation-Mediated NeurodegenerationThe American Journal of Pathology, 2007
- Neuroinflammation: a potential therapeutic targetEmerging Therapeutic Targets, 2005
- Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13Gene, 2003
- Nonsteroidal Anti-Inflammatory Drug Use and the Risk for Alzheimer???s DiseaseDrugs, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996